Study reveals potential new strategy for managing inflammatory bowel disease
Celltrion unveils promising dose escalation results for subcutaneous infliximab
Related Posts
Study finds 3D-printed blood vessels could improve heart bypass outcomes
Coronary heart disease is the most common form of heart and circulatory disease Researchers from […]
KCL joins new project launched by European consortium to improve newborn health
The HYPIEND project consists of 14 partners from eight European countries King’s College London (KCL) […]
Katharina Pink – PharmaTimes
Aspire Pharma has appointed Katharina Pink as Chief Commercial Officer Aspire Pharma has announced the […]